Glutamine kinetics and protein turnover in end-stage renal disease

1 Divisions of Nephrology and 2 Epidemiology and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque; 3 Albuquerque Academy, Albuquerque, New Mexico; 4 Department of Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana; and 5 Department o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2005-01, Vol.288 (1), p.E37-E46
Hauptverfasser: Raj, Dominic S. C, Welbourne, Tomas, Dominic, Elizabeth A, Waters, Debra, Wolfe, Robert, Ferrando, Arny
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Divisions of Nephrology and 2 Epidemiology and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque; 3 Albuquerque Academy, Albuquerque, New Mexico; 4 Department of Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana; and 5 Department of Surgery, University of Texas Medical Branch, Galveston, Texas Submitted 7 June 2004 ; accepted in final form 12 July 2004 Alanine and glutamine constitute the two most important nitrogen carriers released from the muscle. We studied the intracellular amino acid transport kinetics and protein turnover in nine end-stage renal disease (ESRD) patients and eight controls by use of stable isotopes of phenylalanine, alanine, and glutamine. The amino acid transport kinetics and protein turnover were calculated with a three-pool model from the amino acid concentrations and enrichment in the artery, vein, and muscle compartments. Muscle protein breakdown was more than synthesis (nmol·min –1 ·100 ml leg –1 ) during hemodialysis (HD) (169.8 ± 20.0 vs. 125.9 ± 21.8, P < 0.05) and in controls (126.9 ± 6.9 vs. 98.4 ± 7.5, P < 0.05), but synthesis and catabolism were comparable pre-HD (100.7 ± 15.7 vs. 103.4 ± 14.8). Whole body protein catabolism decreased by 15% during HD. The intracellular appearance of alanine (399.0 ± 47.1 vs. 243.0 ± 34.689) and glutamine (369.7 ± 40.6 vs. 235.6 ± 27.5) from muscle protein breakdown increased during dialysis (nmol·min –1 ·100 ml leg –1 , P < 0.01). However, the de novo synthesis of alanine (3,468.9 ± 572.2 vs. 3,140.5 ± 467.7) and glutamine (1,751.4 ± 82.6 vs. 1,782.2 ± 86.4) did not change significantly intradialysis (nmol·min –1 ·100 ml leg –1 ). Branched-chain amino acid catabolism (191.8 ± 63.4 vs. –59.1 ± 42.9) and nonprotein glutamate disposal (347.0 ± 46.3 vs. 222.3 ± 43.6) increased intradialysis compared with pre-HD (nmol·min –1 ·100 ml leg –1 , P < 0.01). The mRNA levels of glutamine synthase (1.45 ± 0.14 vs. 0.33 ± 0.08, P < 0.001) and branched-chain keto acid dehydrogenase-E2 (3.86 ± 0.48 vs. 2.14 ± 0.27, P < 0.05) in the muscle increased during HD. Thus intracellular concentrations of alanine and glutamine are maintained during HD by augmented release of the amino acids from muscle protein catabolism. Although muscle protein breakdown increased intradialysis, the whole body protein catabolism decreased, suggesting central utilization of amino acids released from skeletal muscle. amino acids; protein catabolism; nitrogen carr
ISSN:0193-1849
1522-1555
DOI:10.1152/ajpendo.00240.2004